nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—liver cancer	0.48	1	CbGaD
Pentamidine—CYP3A5—Sorafenib—liver cancer	0.0467	0.195	CbGbCtD
Pentamidine—CYP2C8—Sorafenib—liver cancer	0.0449	0.188	CbGbCtD
Pentamidine—CYP2C19—Sorafenib—liver cancer	0.0377	0.157	CbGbCtD
Pentamidine—CYP1A2—Sorafenib—liver cancer	0.0347	0.145	CbGbCtD
Pentamidine—CYP2D6—Sorafenib—liver cancer	0.0286	0.12	CbGbCtD
Pentamidine—CYP3A4—Sorafenib—liver cancer	0.0182	0.0761	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—liver cancer	0.0174	0.0726	CbGbCtD
Pentamidine—CYP3A4—Doxorubicin—liver cancer	0.011	0.0462	CbGbCtD
Pentamidine—Ospemifene—ESR1—liver cancer	0.00264	1	CrCbGaD
Pentamidine—Leukopenia—Sorafenib—liver cancer	0.000556	0.00398	CcSEcCtD
Pentamidine—Creatinine increased—Epirubicin—liver cancer	0.000552	0.00395	CcSEcCtD
Pentamidine—Loss of consciousness—Sorafenib—liver cancer	0.000546	0.00391	CcSEcCtD
Pentamidine—Cough—Sorafenib—liver cancer	0.000542	0.00388	CcSEcCtD
Pentamidine—Gait disturbance—Epirubicin—liver cancer	0.000538	0.00385	CcSEcCtD
Pentamidine—Hypertension—Sorafenib—liver cancer	0.000537	0.00384	CcSEcCtD
Pentamidine—Hypocalcaemia—Doxorubicin—liver cancer	0.000531	0.0038	CcSEcCtD
Pentamidine—Arthralgia—Sorafenib—liver cancer	0.000529	0.00379	CcSEcCtD
Pentamidine—Myalgia—Sorafenib—liver cancer	0.000529	0.00379	CcSEcCtD
Pentamidine—Ventricular tachycardia—Epirubicin—liver cancer	0.000525	0.00376	CcSEcCtD
Pentamidine—Dry mouth—Sorafenib—liver cancer	0.000517	0.0037	CcSEcCtD
Pentamidine—Hyperkalaemia—Epirubicin—liver cancer	0.000516	0.00369	CcSEcCtD
Pentamidine—Melaena—Epirubicin—liver cancer	0.000513	0.00367	CcSEcCtD
Pentamidine—Creatinine increased—Doxorubicin—liver cancer	0.000511	0.00365	CcSEcCtD
Pentamidine—Salivary hypersecretion—Epirubicin—liver cancer	0.00051	0.00365	CcSEcCtD
Pentamidine—Anaphylactic shock—Sorafenib—liver cancer	0.000507	0.00363	CcSEcCtD
Pentamidine—Colitis—Epirubicin—liver cancer	0.000504	0.00361	CcSEcCtD
Pentamidine—Infection—Sorafenib—liver cancer	0.000504	0.00361	CcSEcCtD
Pentamidine—Skin exfoliation—Epirubicin—liver cancer	0.000502	0.00359	CcSEcCtD
Pentamidine—Candida infection—Epirubicin—liver cancer	0.000502	0.00359	CcSEcCtD
Pentamidine—Shock—Sorafenib—liver cancer	0.000499	0.00357	CcSEcCtD
Pentamidine—Gait disturbance—Doxorubicin—liver cancer	0.000498	0.00356	CcSEcCtD
Pentamidine—Thrombocytopenia—Sorafenib—liver cancer	0.000497	0.00355	CcSEcCtD
Pentamidine—Blood urea increased—Epirubicin—liver cancer	0.000496	0.00355	CcSEcCtD
Pentamidine—Neuropathy—Epirubicin—liver cancer	0.000493	0.00353	CcSEcCtD
Pentamidine—Ventricular tachycardia—Doxorubicin—liver cancer	0.000486	0.00348	CcSEcCtD
Pentamidine—Anorexia—Sorafenib—liver cancer	0.000483	0.00346	CcSEcCtD
Pentamidine—Hyperkalaemia—Doxorubicin—liver cancer	0.000478	0.00342	CcSEcCtD
Pentamidine—Mouth ulceration—Epirubicin—liver cancer	0.000475	0.0034	CcSEcCtD
Pentamidine—Melaena—Doxorubicin—liver cancer	0.000475	0.0034	CcSEcCtD
Pentamidine—Salivary hypersecretion—Doxorubicin—liver cancer	0.000472	0.00338	CcSEcCtD
Pentamidine—Colitis—Doxorubicin—liver cancer	0.000467	0.00334	CcSEcCtD
Pentamidine—Skin exfoliation—Doxorubicin—liver cancer	0.000464	0.00332	CcSEcCtD
Pentamidine—Candida infection—Doxorubicin—liver cancer	0.000464	0.00332	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000462	0.00331	CcSEcCtD
Pentamidine—Blood urea increased—Doxorubicin—liver cancer	0.000459	0.00328	CcSEcCtD
Pentamidine—Neuropathy—Doxorubicin—liver cancer	0.000456	0.00327	CcSEcCtD
Pentamidine—Sepsis—Epirubicin—liver cancer	0.000456	0.00326	CcSEcCtD
Pentamidine—Dyspnoea—Sorafenib—liver cancer	0.000452	0.00324	CcSEcCtD
Pentamidine—Dyspepsia—Sorafenib—liver cancer	0.000446	0.00319	CcSEcCtD
Pentamidine—Phlebitis—Epirubicin—liver cancer	0.000443	0.00317	CcSEcCtD
Pentamidine—Decreased appetite—Sorafenib—liver cancer	0.000441	0.00315	CcSEcCtD
Pentamidine—Mouth ulceration—Doxorubicin—liver cancer	0.00044	0.00314	CcSEcCtD
Pentamidine—Diabetes mellitus—Epirubicin—liver cancer	0.000438	0.00314	CcSEcCtD
Pentamidine—Fatigue—Sorafenib—liver cancer	0.000437	0.00313	CcSEcCtD
Pentamidine—Hepatic function abnormal—Epirubicin—liver cancer	0.000436	0.00312	CcSEcCtD
Pentamidine—Pain—Sorafenib—liver cancer	0.000434	0.0031	CcSEcCtD
Pentamidine—Constipation—Sorafenib—liver cancer	0.000434	0.0031	CcSEcCtD
Pentamidine—Eye pain—Epirubicin—liver cancer	0.000422	0.00302	CcSEcCtD
Pentamidine—Sepsis—Doxorubicin—liver cancer	0.000422	0.00302	CcSEcCtD
Pentamidine—Gastrointestinal pain—Sorafenib—liver cancer	0.000415	0.00297	CcSEcCtD
Pentamidine—Renal failure acute—Epirubicin—liver cancer	0.000413	0.00296	CcSEcCtD
Pentamidine—Phlebitis—Doxorubicin—liver cancer	0.00041	0.00293	CcSEcCtD
Pentamidine—Diabetes mellitus—Doxorubicin—liver cancer	0.000406	0.0029	CcSEcCtD
Pentamidine—Hepatic function abnormal—Doxorubicin—liver cancer	0.000404	0.00289	CcSEcCtD
Pentamidine—Urticaria—Sorafenib—liver cancer	0.000403	0.00288	CcSEcCtD
Pentamidine—Body temperature increased—Sorafenib—liver cancer	0.000401	0.00287	CcSEcCtD
Pentamidine—Abdominal pain—Sorafenib—liver cancer	0.000401	0.00287	CcSEcCtD
Pentamidine—Renal impairment—Epirubicin—liver cancer	0.000401	0.00287	CcSEcCtD
Pentamidine—Eye pain—Doxorubicin—liver cancer	0.000391	0.0028	CcSEcCtD
Pentamidine—Hypoglycaemia—Epirubicin—liver cancer	0.000391	0.0028	CcSEcCtD
Pentamidine—Lethargy—Epirubicin—liver cancer	0.000389	0.00278	CcSEcCtD
Pentamidine—Cerebrovascular accident—Epirubicin—liver cancer	0.000389	0.00278	CcSEcCtD
Pentamidine—Renal failure acute—Doxorubicin—liver cancer	0.000382	0.00273	CcSEcCtD
Pentamidine—Affect lability—Epirubicin—liver cancer	0.000375	0.00269	CcSEcCtD
Pentamidine—Hypersensitivity—Sorafenib—liver cancer	0.000374	0.00267	CcSEcCtD
Pentamidine—Renal impairment—Doxorubicin—liver cancer	0.000371	0.00265	CcSEcCtD
Pentamidine—Face oedema—Epirubicin—liver cancer	0.000368	0.00263	CcSEcCtD
Pentamidine—Asthenia—Sorafenib—liver cancer	0.000364	0.0026	CcSEcCtD
Pentamidine—Hypoglycaemia—Doxorubicin—liver cancer	0.000362	0.00259	CcSEcCtD
Pentamidine—Mood swings—Epirubicin—liver cancer	0.000361	0.00258	CcSEcCtD
Pentamidine—Lethargy—Doxorubicin—liver cancer	0.00036	0.00258	CcSEcCtD
Pentamidine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00036	0.00258	CcSEcCtD
Pentamidine—Pruritus—Sorafenib—liver cancer	0.000359	0.00257	CcSEcCtD
Pentamidine—Blood creatinine increased—Epirubicin—liver cancer	0.000357	0.00256	CcSEcCtD
Pentamidine—Liver function test abnormal—Epirubicin—liver cancer	0.000352	0.00252	CcSEcCtD
Pentamidine—Dry skin—Epirubicin—liver cancer	0.00035	0.0025	CcSEcCtD
Pentamidine—Affect lability—Doxorubicin—liver cancer	0.000347	0.00249	CcSEcCtD
Pentamidine—Diarrhoea—Sorafenib—liver cancer	0.000347	0.00248	CcSEcCtD
Pentamidine—Face oedema—Doxorubicin—liver cancer	0.000341	0.00244	CcSEcCtD
Pentamidine—Gastritis—Epirubicin—liver cancer	0.000338	0.00241	CcSEcCtD
Pentamidine—Dizziness—Sorafenib—liver cancer	0.000335	0.0024	CcSEcCtD
Pentamidine—Mood swings—Doxorubicin—liver cancer	0.000334	0.00239	CcSEcCtD
Pentamidine—Blood creatinine increased—Doxorubicin—liver cancer	0.000331	0.00237	CcSEcCtD
Pentamidine—Influenza—Epirubicin—liver cancer	0.00033	0.00236	CcSEcCtD
Pentamidine—Asthma—Epirubicin—liver cancer	0.00033	0.00236	CcSEcCtD
Pentamidine—Eosinophilia—Epirubicin—liver cancer	0.000326	0.00234	CcSEcCtD
Pentamidine—Liver function test abnormal—Doxorubicin—liver cancer	0.000326	0.00233	CcSEcCtD
Pentamidine—Dry skin—Doxorubicin—liver cancer	0.000323	0.00231	CcSEcCtD
Pentamidine—Pancreatitis—Epirubicin—liver cancer	0.000323	0.00231	CcSEcCtD
Pentamidine—Vomiting—Sorafenib—liver cancer	0.000322	0.00231	CcSEcCtD
Pentamidine—Rash—Sorafenib—liver cancer	0.00032	0.00229	CcSEcCtD
Pentamidine—Dermatitis—Sorafenib—liver cancer	0.000319	0.00229	CcSEcCtD
Pentamidine—Headache—Sorafenib—liver cancer	0.000318	0.00227	CcSEcCtD
Pentamidine—Bronchitis—Epirubicin—liver cancer	0.000317	0.00227	CcSEcCtD
Pentamidine—Pancytopenia—Epirubicin—liver cancer	0.000313	0.00224	CcSEcCtD
Pentamidine—Gastritis—Doxorubicin—liver cancer	0.000312	0.00223	CcSEcCtD
Pentamidine—Neutropenia—Epirubicin—liver cancer	0.000308	0.00221	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—liver cancer	0.000305	0.00218	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—liver cancer	0.000305	0.00218	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—liver cancer	0.000302	0.00216	CcSEcCtD
Pentamidine—Nausea—Sorafenib—liver cancer	0.000301	0.00216	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—liver cancer	0.000299	0.00214	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—liver cancer	0.000297	0.00213	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—liver cancer	0.000294	0.0021	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—liver cancer	0.000293	0.0021	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000291	0.00208	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—liver cancer	0.00029	0.00207	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—liver cancer	0.000289	0.00207	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—liver cancer	0.000288	0.00206	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—liver cancer	0.000286	0.00205	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—liver cancer	0.000286	0.00204	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—liver cancer	0.000285	0.00204	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—liver cancer	0.00028	0.002	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—liver cancer	0.000276	0.00197	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—liver cancer	0.000275	0.00197	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—liver cancer	0.000272	0.00195	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00027	0.00193	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—liver cancer	0.000269	0.00192	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—liver cancer	0.000267	0.00191	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000267	0.00191	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—liver cancer	0.000265	0.0019	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—liver cancer	0.000264	0.00189	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—liver cancer	0.000264	0.00189	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—liver cancer	0.000264	0.00189	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—liver cancer	0.000263	0.00188	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—liver cancer	0.000262	0.00187	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—liver cancer	0.00026	0.00186	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—liver cancer	0.000259	0.00186	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—liver cancer	0.000255	0.00183	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—liver cancer	0.000249	0.00178	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—liver cancer	0.000249	0.00178	CcSEcCtD
Pentamidine—Flushing—Epirubicin—liver cancer	0.000245	0.00175	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—liver cancer	0.000245	0.00175	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—liver cancer	0.000244	0.00175	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—liver cancer	0.000243	0.00174	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—liver cancer	0.000242	0.00173	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—liver cancer	0.00024	0.00172	CcSEcCtD
Pentamidine—Chills—Epirubicin—liver cancer	0.000237	0.00169	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—liver cancer	0.000236	0.00169	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—liver cancer	0.000231	0.00165	CcSEcCtD
Pentamidine—Erythema—Epirubicin—liver cancer	0.00023	0.00164	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—liver cancer	0.000227	0.00162	CcSEcCtD
Pentamidine—Tension—Epirubicin—liver cancer	0.000225	0.00161	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—liver cancer	0.000225	0.00161	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—liver cancer	0.000223	0.0016	CcSEcCtD
Pentamidine—Chills—Doxorubicin—liver cancer	0.000219	0.00157	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—liver cancer	0.000218	0.00156	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—liver cancer	0.000216	0.00155	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—liver cancer	0.000213	0.00152	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—liver cancer	0.000212	0.00152	CcSEcCtD
Pentamidine—Tension—Doxorubicin—liver cancer	0.000209	0.00149	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—liver cancer	0.000208	0.00149	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—liver cancer	0.000206	0.00148	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—liver cancer	0.000206	0.00148	CcSEcCtD
Pentamidine—Syncope—Epirubicin—liver cancer	0.000206	0.00147	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—liver cancer	0.000206	0.00147	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—liver cancer	0.000203	0.00145	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—liver cancer	0.000202	0.00144	CcSEcCtD
Pentamidine—Cough—Epirubicin—liver cancer	0.0002	0.00143	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—liver cancer	0.0002	0.00143	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—liver cancer	0.000199	0.00142	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—liver cancer	0.000198	0.00142	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—liver cancer	0.000196	0.00141	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—liver cancer	0.000196	0.0014	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—liver cancer	0.000196	0.0014	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—liver cancer	0.000196	0.0014	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—liver cancer	0.000195	0.00139	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—liver cancer	0.000193	0.00138	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—liver cancer	0.000191	0.00137	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—liver cancer	0.000191	0.00137	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—liver cancer	0.000191	0.00136	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—liver cancer	0.00019	0.00136	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—liver cancer	0.000189	0.00135	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—liver cancer	0.000188	0.00134	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—liver cancer	0.000187	0.00134	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—liver cancer	0.000187	0.00134	CcSEcCtD
Pentamidine—Infection—Epirubicin—liver cancer	0.000186	0.00133	CcSEcCtD
Pentamidine—Cough—Doxorubicin—liver cancer	0.000185	0.00133	CcSEcCtD
Pentamidine—Shock—Epirubicin—liver cancer	0.000184	0.00132	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—liver cancer	0.000184	0.00132	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—liver cancer	0.000184	0.00131	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—liver cancer	0.000183	0.00131	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—liver cancer	0.000183	0.00131	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—liver cancer	0.000181	0.00129	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—liver cancer	0.000181	0.00129	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—liver cancer	0.000181	0.00129	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—liver cancer	0.00018	0.00129	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—liver cancer	0.000179	0.00128	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—liver cancer	0.000179	0.00128	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—liver cancer	0.000177	0.00127	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—liver cancer	0.000175	0.00125	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—liver cancer	0.000175	0.00125	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—liver cancer	0.000173	0.00124	CcSEcCtD
Pentamidine—Infection—Doxorubicin—liver cancer	0.000172	0.00123	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000171	0.00122	CcSEcCtD
Pentamidine—Shock—Doxorubicin—liver cancer	0.000171	0.00122	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—liver cancer	0.00017	0.00121	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—liver cancer	0.00017	0.00121	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—liver cancer	0.000169	0.00121	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—liver cancer	0.000168	0.0012	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—liver cancer	0.000167	0.0012	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—liver cancer	0.000167	0.00119	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—liver cancer	0.000165	0.00118	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—liver cancer	0.000165	0.00118	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—liver cancer	0.000163	0.00117	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—liver cancer	0.000162	0.00116	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—liver cancer	0.000162	0.00116	CcSEcCtD
Pentamidine—Pain—Epirubicin—liver cancer	0.00016	0.00115	CcSEcCtD
Pentamidine—Constipation—Epirubicin—liver cancer	0.00016	0.00115	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000158	0.00113	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—liver cancer	0.000157	0.00112	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—liver cancer	0.000156	0.00111	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—liver cancer	0.000155	0.00111	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—liver cancer	0.000154	0.00111	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—liver cancer	0.000154	0.0011	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—liver cancer	0.000153	0.0011	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—liver cancer	0.000153	0.00109	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—liver cancer	0.000151	0.00108	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—liver cancer	0.00015	0.00107	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—liver cancer	0.000149	0.00107	CcSEcCtD
Pentamidine—Pain—Doxorubicin—liver cancer	0.000148	0.00106	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—liver cancer	0.000148	0.00106	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—liver cancer	0.000148	0.00106	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—liver cancer	0.000148	0.00106	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—liver cancer	0.000143	0.00102	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000142	0.00101	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—liver cancer	0.000138	0.000988	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—liver cancer	0.000138	0.000986	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—liver cancer	0.000137	0.000981	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—liver cancer	0.000137	0.000981	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—liver cancer	0.000134	0.000962	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—liver cancer	0.000133	0.000949	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—liver cancer	0.000128	0.000918	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—liver cancer	0.000128	0.000914	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—liver cancer	0.000124	0.00089	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—liver cancer	0.000124	0.000887	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—liver cancer	0.000123	0.000878	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—liver cancer	0.000119	0.000853	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—liver cancer	0.000119	0.000849	CcSEcCtD
Pentamidine—Rash—Epirubicin—liver cancer	0.000118	0.000846	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—liver cancer	0.000118	0.000845	CcSEcCtD
Pentamidine—Headache—Epirubicin—liver cancer	0.000117	0.00084	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—liver cancer	0.000115	0.000821	CcSEcCtD
Pentamidine—Nausea—Epirubicin—liver cancer	0.000111	0.000797	CcSEcCtD
Pentamidine—Vomiting—Doxorubicin—liver cancer	0.00011	0.000789	CcSEcCtD
Pentamidine—Rash—Doxorubicin—liver cancer	0.000109	0.000782	CcSEcCtD
Pentamidine—Dermatitis—Doxorubicin—liver cancer	0.000109	0.000782	CcSEcCtD
Pentamidine—Headache—Doxorubicin—liver cancer	0.000109	0.000777	CcSEcCtD
Pentamidine—Nausea—Doxorubicin—liver cancer	0.000103	0.000737	CcSEcCtD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.17e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTA3—liver cancer	2.17e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.17e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTA2—liver cancer	2.16e-05	0.000156	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALDOB—liver cancer	2.16e-05	0.000156	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—liver cancer	2.15e-05	0.000155	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—JUN—liver cancer	2.14e-05	0.000155	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EPT1—liver cancer	2.13e-05	0.000154	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—liver cancer	2.13e-05	0.000153	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CPT1B—liver cancer	2.1e-05	0.000152	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GLUL—liver cancer	2.1e-05	0.000152	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—liver cancer	2.09e-05	0.000151	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTA1—liver cancer	2.09e-05	0.00015	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MMP9—liver cancer	2.09e-05	0.00015	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CG—liver cancer	2.08e-05	0.00015	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN1A—liver cancer	2.08e-05	0.00015	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NAT2—liver cancer	2.06e-05	0.000149	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CRABP1—liver cancer	2.06e-05	0.000148	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK8—liver cancer	2.03e-05	0.000146	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NR1H4—liver cancer	2.03e-05	0.000146	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TAT—liver cancer	2.02e-05	0.000146	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PPARG—liver cancer	2.01e-05	0.000145	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL6—liver cancer	2e-05	0.000144	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTA3—liver cancer	1.99e-05	0.000144	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.99e-05	0.000143	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTA4—liver cancer	1.98e-05	0.000143	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALDOB—liver cancer	1.98e-05	0.000143	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.94e-05	0.00014	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTA2—liver cancer	1.93e-05	0.000139	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.93e-05	0.000139	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HPGDS—liver cancer	1.91e-05	0.000137	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CRABP1—liver cancer	1.89e-05	0.000136	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—liver cancer	1.87e-05	0.000135	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTA1—liver cancer	1.86e-05	0.000134	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—liver cancer	1.86e-05	0.000134	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.85e-05	0.000134	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—liver cancer	1.85e-05	0.000133	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NAT2—liver cancer	1.84e-05	0.000133	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CD—liver cancer	1.83e-05	0.000132	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTA4—liver cancer	1.82e-05	0.000131	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—ALB—liver cancer	1.81e-05	0.00013	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HPGDS—liver cancer	1.8e-05	0.00013	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.79e-05	0.000129	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CPT1B—liver cancer	1.78e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GLUL—liver cancer	1.78e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTA2—liver cancer	1.78e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.77e-05	0.000128	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALDOB—liver cancer	1.77e-05	0.000127	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MYC—liver cancer	1.72e-05	0.000124	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TGFB1—liver cancer	1.72e-05	0.000124	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NR1H4—liver cancer	1.72e-05	0.000124	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTA1—liver cancer	1.71e-05	0.000124	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.7e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PSMD10—liver cancer	1.7e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PSMA4—liver cancer	1.7e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NAT2—liver cancer	1.7e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTA3—liver cancer	1.69e-05	0.000122	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CRABP1—liver cancer	1.69e-05	0.000121	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GOT2—liver cancer	1.65e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HPGDS—liver cancer	1.65e-05	0.000119	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.64e-05	0.000118	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.63e-05	0.000117	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALDOB—liver cancer	1.63e-05	0.000117	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.61e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PSMD10—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PSMA4—liver cancer	1.6e-05	0.000116	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CB—liver cancer	1.59e-05	0.000115	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—liver cancer	1.59e-05	0.000115	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GOT2—liver cancer	1.56e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP2E1—liver cancer	1.55e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CRABP1—liver cancer	1.55e-05	0.000112	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTA4—liver cancer	1.54e-05	0.000111	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.52e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.51e-05	0.000109	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTA2—liver cancer	1.51e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.49e-05	0.000108	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.48e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HPGDS—liver cancer	1.47e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PSMD10—liver cancer	1.47e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PSMA4—liver cancer	1.47e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP2E1—liver cancer	1.47e-05	0.000106	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.46e-05	0.000106	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—liver cancer	1.46e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYCS—liver cancer	1.45e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTA1—liver cancer	1.45e-05	0.000105	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NAT2—liver cancer	1.44e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GOT2—liver cancer	1.43e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GGT1—liver cancer	1.43e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GOT1—liver cancer	1.43e-05	0.000103	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.42e-05	0.000102	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—liver cancer	1.42e-05	0.000102	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.38e-05	9.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALDOB—liver cancer	1.38e-05	9.92e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CPT1B—liver cancer	1.37e-05	9.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GLUL—liver cancer	1.37e-05	9.91e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYCS—liver cancer	1.37e-05	9.89e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HPGDS—liver cancer	1.36e-05	9.76e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—liver cancer	1.35e-05	9.75e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GGT1—liver cancer	1.35e-05	9.71e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GOT1—liver cancer	1.35e-05	9.71e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP2E1—liver cancer	1.35e-05	9.69e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.33e-05	9.61e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NR1H4—liver cancer	1.33e-05	9.55e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.32e-05	9.49e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CRABP1—liver cancer	1.31e-05	9.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PSMA4—liver cancer	1.31e-05	9.46e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PSMD10—liver cancer	1.31e-05	9.46e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA3—liver cancer	1.3e-05	9.39e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.3e-05	9.39e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL6—liver cancer	1.3e-05	9.34e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTP1—liver cancer	1.28e-05	9.23e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GOT2—liver cancer	1.28e-05	9.2e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—HMOX1—liver cancer	1.26e-05	9.1e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYCS—liver cancer	1.26e-05	9.07e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GOT1—liver cancer	1.24e-05	8.9e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GGT1—liver cancer	1.24e-05	8.9e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTP1—liver cancer	1.21e-05	8.72e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PSMA4—liver cancer	1.21e-05	8.7e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PSMD10—liver cancer	1.21e-05	8.7e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP2E1—liver cancer	1.2e-05	8.65e-05	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—liver cancer	1.2e-05	8.61e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—HMOX1—liver cancer	1.19e-05	8.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA4—liver cancer	1.19e-05	8.59e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.18e-05	8.52e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—liver cancer	1.18e-05	8.48e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GOT2—liver cancer	1.17e-05	8.47e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.16e-05	8.38e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA2—liver cancer	1.16e-05	8.37e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HPGDS—liver cancer	1.15e-05	8.27e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.14e-05	8.22e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYCS—liver cancer	1.12e-05	8.1e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTA1—liver cancer	1.12e-05	8.08e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1A1—liver cancer	1.12e-05	8.04e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—liver cancer	1.11e-05	8.01e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTP1—liver cancer	1.11e-05	8e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAT2—liver cancer	1.11e-05	7.98e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP2E1—liver cancer	1.1e-05	7.96e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GOT1—liver cancer	1.1e-05	7.94e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GGT1—liver cancer	1.1e-05	7.94e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—HMOX1—liver cancer	1.09e-05	7.88e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALDOB—liver cancer	1.06e-05	7.66e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—liver cancer	1.04e-05	7.5e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.04e-05	7.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYCS—liver cancer	1.03e-05	7.45e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.03e-05	7.39e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PSMA4—liver cancer	1.02e-05	7.37e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PSMD10—liver cancer	1.02e-05	7.37e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARA—liver cancer	1.02e-05	7.35e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—liver cancer	1.02e-05	7.35e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GGT1—liver cancer	1.01e-05	7.31e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GOT1—liver cancer	1.01e-05	7.31e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CRABP1—liver cancer	1.01e-05	7.3e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GOT2—liver cancer	9.95e-06	7.17e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTP1—liver cancer	9.91e-06	7.14e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—liver cancer	9.83e-06	7.08e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—HMOX1—liver cancer	9.77e-06	7.04e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—liver cancer	9.72e-06	7e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1A1—liver cancer	9.67e-06	6.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARA—liver cancer	9.64e-06	6.95e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP2E1—liver cancer	9.36e-06	6.74e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTP1—liver cancer	9.11e-06	6.56e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—liver cancer	9.1e-06	6.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.06e-06	6.53e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—liver cancer	9.01e-06	6.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—HMOX1—liver cancer	8.98e-06	6.47e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HPGDS—liver cancer	8.86e-06	6.38e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARA—liver cancer	8.84e-06	6.37e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYCS—liver cancer	8.76e-06	6.31e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CG—liver cancer	8.74e-06	6.3e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.66e-06	6.24e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A1—liver cancer	8.63e-06	6.22e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GOT1—liver cancer	8.59e-06	6.19e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GGT1—liver cancer	8.59e-06	6.19e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PPARG—liver cancer	8.44e-06	6.08e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—liver cancer	8.37e-06	6.03e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CG—liver cancer	8.26e-06	5.95e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—liver cancer	8.04e-06	5.8e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PPARG—liver cancer	7.97e-06	5.74e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.94e-06	5.72e-05	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—liver cancer	7.94e-06	5.72e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A1—liver cancer	7.94e-06	5.72e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PSMA4—liver cancer	7.9e-06	5.69e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PSMD10—liver cancer	7.9e-06	5.69e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARA—liver cancer	7.89e-06	5.69e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTP1—liver cancer	7.72e-06	5.56e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CD—liver cancer	7.69e-06	5.54e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GOT2—liver cancer	7.68e-06	5.53e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—HMOX1—liver cancer	7.61e-06	5.48e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—ALB—liver cancer	7.59e-06	5.47e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CG—liver cancer	7.57e-06	5.46e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—liver cancer	7.4e-06	5.33e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PPARG—liver cancer	7.31e-06	5.27e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CD—liver cancer	7.26e-06	5.23e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARA—liver cancer	7.26e-06	5.23e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP2E1—liver cancer	7.22e-06	5.2e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—ALB—liver cancer	7.17e-06	5.16e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—liver cancer	7.09e-06	5.11e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.09e-06	5.11e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CG—liver cancer	6.76e-06	4.87e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYCS—liver cancer	6.76e-06	4.87e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1A1—liver cancer	6.72e-06	4.84e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CB—liver cancer	6.7e-06	4.83e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CD—liver cancer	6.66e-06	4.8e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GGT1—liver cancer	6.63e-06	4.78e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GOT1—liver cancer	6.63e-06	4.78e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—ALB—liver cancer	6.57e-06	4.73e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PPARG—liver cancer	6.52e-06	4.7e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CB—liver cancer	6.33e-06	4.56e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—liver cancer	6.27e-06	4.52e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CG—liver cancer	6.22e-06	4.48e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARA—liver cancer	6.15e-06	4.43e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PPARG—liver cancer	6e-06	4.32e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTP1—liver cancer	5.96e-06	4.29e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CD—liver cancer	5.94e-06	4.28e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—HMOX1—liver cancer	5.87e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—ALB—liver cancer	5.87e-06	4.23e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CB—liver cancer	5.8e-06	4.18e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.52e-06	3.98e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—liver cancer	5.47e-06	3.94e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CD—liver cancer	5.46e-06	3.94e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—ALB—liver cancer	5.39e-06	3.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CG—liver cancer	5.27e-06	3.79e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A1—liver cancer	5.19e-06	3.74e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CB—liver cancer	5.18e-06	3.73e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PPARG—liver cancer	5.08e-06	3.66e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—liver cancer	4.84e-06	3.49e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CB—liver cancer	4.76e-06	3.43e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARA—liver cancer	4.75e-06	3.42e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CD—liver cancer	4.63e-06	3.34e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—ALB—liver cancer	4.57e-06	3.29e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—liver cancer	4.08e-06	2.94e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CG—liver cancer	4.06e-06	2.93e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CB—liver cancer	4.04e-06	2.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PPARG—liver cancer	3.92e-06	2.83e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—liver cancer	3.86e-06	2.78e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CD—liver cancer	3.57e-06	2.57e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—liver cancer	3.54e-06	2.55e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—ALB—liver cancer	3.53e-06	2.54e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—liver cancer	3.34e-06	2.4e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—liver cancer	3.16e-06	2.27e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—liver cancer	3.15e-06	2.27e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CB—liver cancer	3.11e-06	2.24e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.9e-06	2.09e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—liver cancer	2.89e-06	2.08e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—liver cancer	2.58e-06	1.86e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—liver cancer	2.46e-06	1.77e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—liver cancer	2.37e-06	1.71e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—liver cancer	2.01e-06	1.45e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.9e-06	1.37e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—liver cancer	1.55e-06	1.12e-05	CbGpPWpGaD
